本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Assembly Biosciences Inc.

26.11
-2.8500-9.84%
盤後26.110.00000.00%16:20 EDT
成交量:58.88萬
成交額:1,562.10萬
市值:5.32億
市盈率:-1.02萬
高:29.66
開:29.00
低:25.31
收:28.96
52周最高:39.71
52周最低:20.23
股本:2,036.06萬
流通股本:917.37萬
量比:1.59
換手率:6.42%
股息:- -
股息率:- -
每股收益(TTM):-0.0026
每股收益(LYR):-0.5461
淨資產收益率:-0.03%
總資產收益率:-2.67%
市淨率:1.74
市盈率(LYR):-47.81

資料載入中...

2023/11/22

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/26

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/10/17

重要事件披露

Form 8-K - Current report
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/29

重要事件披露

Form 8-K - Current report
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/30

重要事件披露

Form 8-K - Current report
2023/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities